基于精度的抗凝管理方法 临界疾病中的抗凝管理方法
William E Dager1,2,3, Toby C Trujillo4,5, Brian W Gilbert6
1University of California, Davis Medical Center, Sacramento, California, USA.
Pharmacotherapy
|August 21, 2023
概括
在重症患者中管理抗凝剂治疗是复杂的,因为有许多变量. 这项研究探讨了个性化的方法,以优化这些具有挑战性的群体中抗凝血剂的安全性和有效性.
科学领域:
- 药理学和重症监护医学 药理学和重症监护医学
- 患者安全和临床管理
背景情况:
- 抗凝剂治疗经常与不良事件有关,特别是在急性护理环境中.
- 在特殊和重症患者群体中管理抗凝血药物存在重大挑战,原因是许多影响变量.
研究的目的:
- 探讨为重症患者制定个性化,基于精度的抗凝管理计划的考虑和方法.
- 帮助临床医生在独特和动态的患者群体中应对抗凝固剂治疗的复杂性.
主要方法:
- 审查现有的文献和临床试验数据对抗凝血在重症患者.
- 探索不同重症监护室 (ICU) 人群中影响血栓形成和血静的因素.
- 讨论管理计划的持续评估和修订策略.
主要成果:
- 临床试验经常排除或不充分考虑危急病患者中存在的变量.
- 动态条件和众多相互影响的因素创造了小的治疗窗口,使抗凝管理复杂化.
- 个性化评估和适应性管理对于ICU中安全有效的抗凝剂至关重要.
结论:
- 在重症患者中有效的抗凝药需要个性化的方法,考虑多种动态变量.
- 临床医生需要特定的技能和思维流程来管理这种复杂的患者群体中的抗凝血药物.
- 基于精度的管理计划对于优化结果和最大限度地降低与ICU中抗凝剂治疗相关的风险至关重要.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Anticoagulant Drugs: Low-Molecular-Weight Heparins
751
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
751
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Venous Thrombosis IV: Nursing Management
14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Acute Coronary Syndrome IV: Interprofessional Care
12
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12


